Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy (Q44594055)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 1, 2003
edit
Language Label Description Also known as
English
Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy
scientific article published on September 1, 2003

    Statements

    title
    Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    14506163
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14506163%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    19 December 2019
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q44594055&oldid=2162421348"